Literature DB >> 23190223

Norovirus gastroenteritis in immunocompromised patients.

Karin Bok1, Kim Y Green.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23190223      PMCID： PMC4944753          DOI： 10.1056/NEJMra1207742

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

1.  Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.

Authors:  N Boillat Blanco; R Kuonen; C Bellini; O Manuel; C Estrade; J Mazza-Stalder; J D Aubert; R Sahli; P Meylan
Journal:  Transpl Infect Dis       Date:  2010-08-30       Impact factor: 2.228

2.  Norovirus gastroenteritis successfully treated with nitazoxanide.

Authors:  Danish M Siddiq; Hoonmo L Koo; Javier A Adachi; George M Viola
Journal:  J Infect       Date:  2011-08-09       Impact factor: 6.072

3.  Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?

Authors:  Diana F Florescu; Elizabeth D Hermsen; Joong Y Kwon; Dalal Gumeel; Wendy J Grant; David F Mercer; Andre C Kalil
Journal:  Pediatr Transplant       Date:  2011-08-23

4.  Norovirus and severe chronic gastroenteritis in pediatric stem cell transplantation: the plot thickens.

Authors:  Naim Alkhouri; Lara Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2011-07-08

5.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

6.  Norovirus-host interaction: multi-selections by human histo-blood group antigens.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2011-06-24       Impact factor: 17.079

7.  New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children.

Authors:  C Henke-Gendo; G Harste; B Juergens-Saathoff; F Mattner; H Deppe; A Heim
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

8.  Abnormal computed tomography findings among children with viral gastroenteritis and symptoms mimicking acute appendicitis.

Authors:  Hitoshi Tajiri; Yuki Kiyohara; Tomoyuki Tanaka; Yuri Etani; Sotaro Mushiake
Journal:  Pediatr Emerg Care       Date:  2008-09       Impact factor: 1.454

9.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  Norovirus infections in preterm infants: wide variety of clinical courses.

Authors:  Sven Armbrust; Axel Kramer; Dirk Olbertz; Kathrin Zimmermann; Christoph Fusch
Journal:  BMC Res Notes       Date:  2009-06-02
View more
  125 in total

1.  Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.

Authors:  Joana Rocha-Pereira; Jana Van Dycke; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 2.  Comparison of Recommendations in Clinical Practice Guidelines for Acute Gastroenteritis in Children.

Authors:  Andrea Lo Vecchio; Jorge Amil Dias; James A Berkley; Chris Boey; Mitchell B Cohen; Sylvia Cruchet; Ilaria Liguoro; Eduardo Salazar Lindo; Bhupinder Sandhu; Philip Sherman; Toshiaki Shimizu; Alfredo Guarino
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-08       Impact factor: 2.839

3.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

4.  Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection.

Authors:  Eric A Levenson; Craig Martens; Kishore Kanakabandi; Charles V Turner; Kimmo Virtaneva; Monica Paneru; Stacy Ricklefs; Stanislav V Sosnovtsev; Jordan A Johnson; Stephen F Porcella; Kim Y Green
Journal:  J Immunol       Date:  2018-05-07       Impact factor: 5.422

Review 5.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

6.  The state of norovirus vaccines.

Authors:  Kari Debbink; Lisa C Lindesmith; Ralph S Baric
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 7.  Chronic norovirus infection and common variable immunodeficiency.

Authors:  J Woodward; E Gkrania-Klotsas; D Kumararatne
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

8.  Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.

Authors:  Anushka C Galasiti Kankanamalage; Yunjeong Kim; Pathum M Weerawarna; Roxanne Adeline Z Uy; Vishnu C Damalanka; Sivakoteswara Rao Mandadapu; Kevin R Alliston; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-03-19       Impact factor: 7.446

9.  Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.

Authors:  Yee Ching Ng; Ye Won Kim; Jeong-Su Lee; Sung Joon Lee; Moon Jung Song
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

Review 10.  Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.

Authors:  Stephanie M Karst; Christiane E Wobus
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.